ahlam1399
09-27-2016, 03:15 AM
Kite immu**therapy drug helps blood cancer patients in study
(Reuters) - Kite Pharma Inc on Monday said its experimental CAR T-cell therapy, which helps the immune system fight cancer, was highly effective in treating aggressive **n-Hodgkin lymphoma, although two deaths were related to the drug, according to interim data from a midstage trial.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=1t67W4xqvog:cCEAATFlSiM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=1t67W4xqvog:cCEAATFlSiM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=1t67W4xqvog:cCEAATFlSiM:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=1t67W4xqvog:cCEAATFlSiM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=1t67W4xqvog:cCEAATFlSiM:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/1t67W4xqvog
(Reuters) - Kite Pharma Inc on Monday said its experimental CAR T-cell therapy, which helps the immune system fight cancer, was highly effective in treating aggressive **n-Hodgkin lymphoma, although two deaths were related to the drug, according to interim data from a midstage trial.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=1t67W4xqvog:cCEAATFlSiM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=1t67W4xqvog:cCEAATFlSiM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=1t67W4xqvog:cCEAATFlSiM:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=1t67W4xqvog:cCEAATFlSiM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=1t67W4xqvog:cCEAATFlSiM:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/1t67W4xqvog